​

Penumbra (PEN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PEN Stock Forecast

Penumbra (PEN) stock forecast, based on 21 Wall Street analysts, predicts a 12-month average price target of $311.00, with a high of $355.00 and a low of $285.00. This represents a -0.17% decline from the last price of $311.52.

$150 $200 $250 $300 $350 $400 High: $355 Avg: $311 Low: $285 Last Closed Price: $311.52

PEN Stock Rating

Penumbra stock's rating consensus is Buy, based on 21 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (80.95%), 4 Hold (19.05%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 21 4 17 0 Strong Sell Sell Hold Buy Strong Buy

PEN Price Target Upside V Benchmarks

TypeNameUpside
StockPenumbra-0.17%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.58%

Price Target Trends

1M3M12M
# Anlaysts-512
Avg Price Target-$311.40$316.25
Last Closing Price$311.52$311.52$311.52
Upside/Downside--0.04%1.52%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 253133-120
Nov, 253133-120
Oct, 252134-120
Sep, 252124--18
Aug, 252124--18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 06, 2025Evercore ISI$286.00$261.389.42%-8.19%
Nov 06, 2025William PlovanicCanaccord Genuity$355.00$268.2632.33%13.96%
Oct 15, 2025Richard NewitterTruist Financial$300.00$254.8017.74%-3.70%
Oct 08, 2025Needham$326.00$249.0430.90%4.65%
Oct 01, 2025Wells Fargo$290.00$253.3214.48%-6.91%
Jul 30, 2025Truist Financial$310.00$254.2121.95%-0.49%
Jul 30, 2025Robert W. Baird$285.00$254.2112.11%-8.51%
Jul 30, 2025UBS$335.00$254.2131.78%7.54%
Jul 30, 2025Canaccord Genuity$350.00$254.2137.68%12.35%
Apr 24, 2025David RescottRobert W. Baird$325.00$298.258.97%4.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2025CitigroupNeutralBuyupgrade
Nov 06, 2025Evercore ISIOutperformOutperformhold
Oct 08, 2025NeedhamHoldBuyupgrade
Sep 02, 2025Evercore ISIOutperforminitialise
Apr 24, 2025UBSBuyBuyhold
Apr 15, 2025RBC CapitalOutperformOutperformhold
Dec 11, 2024Wells FargoEqual-WeightOverweightupgrade
Oct 31, 2024RBC CapitalOutperformOutperformhold
Oct 31, 2024Deutsche BankBuyBuyhold
Oct 18, 2024Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 $7 $8 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.54$0.07$-0.05$2.37$0.36----
Avg Forecast$-0.18$0.81$0.15$2.03$2.79$3.80$4.96$6.32$7.56
High Forecast$-0.17$0.83$0.16$2.20$2.97$4.37$5.83$6.87$7.72
Low Forecast$-0.18$0.80$0.15$1.90$2.68$3.49$4.46$5.76$7.35
Surprise %200.00%-91.36%-133.33%16.75%-87.10%----

Revenue Forecast

$500M $900M $1B $2B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$560.41M$747.59M$847.13M$1.06B$1.19B----
Avg Forecast$548.91M$738.09M$843.69M$1.06B$1.19B$1.36B$1.56B$1.76B$1.98B
High Forecast$560.31M$753.42M$854.36M$1.08B$1.20B$1.38B$1.56B$1.77B$2.01B
Low Forecast$541.38M$727.97M$829.90M$1.04B$1.17B$1.34B$1.56B$1.75B$1.93B
Surprise %2.10%1.29%0.41%-0.20%0.33%----

Net Income Forecast

$-50M $30M $110M $190M $270M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-19.26M$2.62M$-2.00M$90.95M$14.01M----
Avg Forecast$-8.11M$-4.05M$-34.15M$90.95M$110.92M$146.01M$192.40M$260.55M$296.48M
High Forecast$4.89M$8.84M$-22.81M$120.73M$116.57M$171.28M$228.83M$269.26M$302.75M
Low Forecast$-21.10M$-16.95M$-45.49M$61.17M$105.26M$136.95M$175.08M$226.04M$288.28M
Surprise %137.52%-164.72%-94.14%--87.37%----

PEN Forecast FAQ

Is Penumbra stock a buy?

Penumbra stock has a consensus rating of Buy, based on 21 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Penumbra is a favorable investment for most analysts.

What is Penumbra's price target?

Penumbra's price target, set by 21 Wall Street analysts, averages $311 over the next 12 months. The price target range spans from $285 at the low end to $355 at the high end, suggesting a potential -0.17% change from the previous closing price of $311.52.

How does Penumbra stock forecast compare to its benchmarks?

Penumbra's stock forecast shows a -0.17% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (19.58%).

What is the breakdown of analyst ratings for Penumbra over the past three months?

  • December 2025: 15.00% Strong Buy, 65.00% Buy, 15.00% Hold, 0% Sell, 5.00% Strong Sell.
  • November 2025: 15.00% Strong Buy, 65.00% Buy, 15.00% Hold, 0% Sell, 5.00% Strong Sell.
  • October 2025: 10.00% Strong Buy, 65.00% Buy, 20.00% Hold, 0% Sell, 5.00% Strong Sell.

What is Penumbra’s EPS forecast?

Penumbra's average annual EPS forecast for its fiscal year ending in December 2025 is $3.8, marking a 955.56% increase from the reported $0.36 in 2024. Estimates for the following years are $4.96 in 2026, $6.32 in 2027, and $7.56 in 2028.

What is Penumbra’s revenue forecast?

Penumbra's average annual revenue forecast for its fiscal year ending in December 2025 is $1.36B, reflecting a 13.98% increase from the reported $1.19B in 2024. The forecast for 2026 is $1.56B, followed by $1.76B for 2027, and $1.98B for 2028.

What is Penumbra’s net income forecast?

Penumbra's net income forecast for the fiscal year ending in December 2025 stands at $146.01M, representing an 942.01% increase from the reported $14.01M in 2024. Projections indicate $192.4M in 2026, $260.55M in 2027, and $296.48M in 2028.